Anand, Ravi
Novartis (United States)
2 papers on CoChatORCID 0000-0002-7204-7786
Most cited papers
- Verified
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000) · The Lancet
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 1,182
- Verified
A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease
Farlow, M., Anand, R., Messina Jr, J., Hartman, R., & Veach, J. (2000) · European Neurology
Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research
Cited by 332
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free